Cite
Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies.
MLA
Fazeli, Mir Sohail, et al. “Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies.” Clinical Medicine Insights: Arthritis & Musculoskeletal Disorders, June 2021, pp. 1–10. EBSCOhost, https://doi.org/10.1177/11795441211028751.
APA
Fazeli, M. S., Khaychuk, V., Wittstock, K., Breznen, B., Crocket, G., Pourrahmat, M.-M., & Ferri, L. (2021). Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies. Clinical Medicine Insights: Arthritis & Musculoskeletal Disorders, 1–10. https://doi.org/10.1177/11795441211028751
Chicago
Fazeli, Mir Sohail, Vadim Khaychuk, Keith Wittstock, Boris Breznen, Grace Crocket, Mir-Masoud Pourrahmat, and Leticia Ferri. 2021. “Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies.” Clinical Medicine Insights: Arthritis & Musculoskeletal Disorders, June, 1–10. doi:10.1177/11795441211028751.